is bpc 157 intramuscular or subcutaneous bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA BPC-157 Peptide - Hormone Replacement
Description
J Physiol Paris 93(6):505512 Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, et al (1997) Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats

Injecting in the evening allows you to sleep through the initial nausea window that some people experience in the first 12 to 24 hours after administration

So for people that suffer from IBS, irritable bowel syndrome, or from colitis, or from other gut issues, There is a potential use for therapeutic peptides

Vegetarians and Stroke Risk FactorsVitamin B12 and Homocysteine
